Harter P, Marme F, Redondo A, Reuss A, et al. Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial. J Clin Oncol 2025 Dec 3:JCO2501210. doi: 10.1200/JCO-25-01210.
PMID: 41337696